Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Bronchodilator effect on O2 deficit and V'O2 kinetics during moderate intensity exercise in normoxemic COPD [chronic obstructive pulmonary disease]

Trial Profile

Bronchodilator effect on O2 deficit and V'O2 kinetics during moderate intensity exercise in normoxemic COPD [chronic obstructive pulmonary disease]

Completed
Phase of Trial: Phase II

Latest Information Update: 28 Apr 2011

At a glance

  • Drugs Ipratropium-bromide/salbutamol (Primary)
  • Indications Chronic obstructive pulmonary disease
  • Focus Pharmacodynamics
  • Most Recent Events

    • 31 Aug 2018 Biomarkers information updated
    • 18 Apr 2011 Status changed from recruiting to completed, according to ClinicalTrials.gov.
    • 22 Sep 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top